PTX
Click for more information
3.70% 3.9¢ prescient therapeutics limited

Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial, page-4

  1. bsher
    244 Posts.
    lightbulb Created with Sketch. 63
    clock Created with Sketch.
    23/12/19
    09:09
    Post #: 42097061
    Overall response rate of 91% in women with locally advanced HER2 negative breast cancer

    Two patients reported pathologic complete responses, another patient with clinical complete response

    Excellent ongoing durability, with 9 of 10 evaluable patients free of disease progression to date, with up to 40 months of disease-free progression

    New study to focus on ER+ breast cancer
    PTX Price at posting: 7.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 20  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢ 		Change
-0.002(3.70%) 		Mkt cap ! $31.40M
Open High Low Value Volume
4.0¢ 4.0¢ 3.9¢ $31.53K 794.9K

Buyers (Bids)

No. Vol. Price($)
8 456872 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 66952 1
View Market Depth
Last trade - 15.43pm 24/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.